Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H G Birnbaum

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Medical Economics|March 2, 2012
Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ I Ivanova, R E Bergman, H G Birnbaum, et al.
Pharmacoeconomics|February 8, 2000
Pharmacoeconomics and health policy. Current applications and prospects for the futureP E Greenberg, A Arcelus, H G Birnbaum, et al.
Journal of Occupational and Environmental Medicine|June 30, 2000
Direct and indirect costs of rheumatoid arthritis to an employerH G Birnbaum, M Barton, P E Greenberg, et al.
Parkinsonism & Related Disorders|December 20, 2011
Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's diseaseA Kaltenboeck, S J Johnson, M R Davis, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 5, 2009
Asthma severity categorization using a claims-based algorithm or pulmonary function testingH G Birnbaum, J I Ivanova, A P Yu, et al.
Health Affairs (Project Hope)|September 25, 1999
Depression in the workplace: effects on short-term disabilityR C Kessler, C Barber, H G Birnbaum, et al.
Journal of Medical Economics|March 13, 2015
The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular riskM S Penn, M A Yenikomshian, A K G Cummings, et al.
Journal of Occupational and Environmental Medicine|February 24, 2001
Depression and work productivity: the comparative costs of treatment versus nontreatmentG E Simon, C Barber, H G Birnbaum, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Medical Economics|March 2, 2012
Impact of medication adherence to disease-modifying drugs on severe relapse, and direct and indirect costs among employees with multiple sclerosis in the USJ I Ivanova, R E Bergman, H G Birnbaum, et al.
Pharmacoeconomics|February 8, 2000
Pharmacoeconomics and health policy. Current applications and prospects for the futureP E Greenberg, A Arcelus, H G Birnbaum, et al.
Journal of Occupational and Environmental Medicine|June 30, 2000
Direct and indirect costs of rheumatoid arthritis to an employerH G Birnbaum, M Barton, P E Greenberg, et al.
Parkinsonism & Related Disorders|December 20, 2011
Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's diseaseA Kaltenboeck, S J Johnson, M R Davis, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|February 5, 2009
Asthma severity categorization using a claims-based algorithm or pulmonary function testingH G Birnbaum, J I Ivanova, A P Yu, et al.
Health Affairs (Project Hope)|September 25, 1999
Depression in the workplace: effects on short-term disabilityR C Kessler, C Barber, H G Birnbaum, et al.
Journal of Medical Economics|March 13, 2015
The economic impact of implementing a multiple inflammatory biomarker-based approach to identify, treat, and reduce cardiovascular riskM S Penn, M A Yenikomshian, A K G Cummings, et al.
Journal of Occupational and Environmental Medicine|February 24, 2001
Depression and work productivity: the comparative costs of treatment versus nontreatmentG E Simon, C Barber, H G Birnbaum, et al.
Pageof 2